For more information regarding COVID-19, visit the Department of Health's information page:
Home arrow News & Events arrow The Majlis Menace arrow New probiotic strain for Nestle infant formula
New probiotic strain for Nestle infant formula Print
Swedish probiotics specialist BioGaia announced a deal with Nestlé Nutrition that will see its proprietary Lactobacillus reuteri strain employed in infant nutrition products globally.

BioGaia’s probiotic ingredient will be used in a new line of Nestlé infant formulas in global markets excluding Japan and Korea – with the first due to hit the market in 2009.

The deal builds on BioGaia’s presence in the infant formula market – Lactobacillus reuteri is already present in infant formula products in Asia and Europe.

The company already supplies Nestlé healthcare nutrition products.

”The agreement is further proof that major organisations appreciate the value of our products, particularly in the area of child health,” said BioGaia president, Peter Rothschild.

“These products are based on many years of research proving good clinical results. The safety demands are naturally very high for this type of product. Our safety data has been a strong factor in facilitating the agreement with Nestlé.”

Nestlé announced in February that it would launch a new range of baby foods called NatureNes backed by a €25m investment.

Nestlé infant formulas manufactured in South Africa are certified Halaal by SANHA.


< Prev   Next >

SANHA Mailing List

 SANHA Mailing List Subscribe

      Twitter      Instagram
This website is powered by NET31